연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
747. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
Koh CS, Ku JL, Park SY, Kim KH, Choi JS, Kim IJ, Park JH, Oh SK, Chung JK, Lee JH, Kim WH, Kim CW, Cho BY, Park JG.
Mol Cell Endocrinol. 2007 Jan 29;264(1-2):118-27. Epub 2006 Nov 28
Link
746. Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter.
Hwang DW, Kang JH, Jeong JM, Chung JK, Lee MC, Kim S, Lee DS.
Eur J Nucl Med Mol Imaging. 2007 Sep 21; [Epub ahead of print]
Link
745. MIDGE/hNIS vaccination generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity.
Choi Y, Jeon YH, Kang JH, Chung JK, Schmidt M, Kim AC.
Int J Cancer. 2007 May 1;120(9):1942-50
Link
744. Immune response to firefly luciferase as a naked DNA.
Jeon YH, Choi Y, Kang JH, Kim CW, Jeong JM, Lee DS, Chung JK.
Cancer Biol Ther. 2007 May;6(5):781-6. Epub 2007 Feb 13
Link
743. Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine.
Jeon YH, Choi Y, Kim HJ, Kim CW, Jeong JM, Lee DS, Chung JK.
Int J Cancer. 2007 Oct 1;121(7):1593-9.
Link
742. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI, Kang JH, Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC.
J Nucl Med. 2007 Sep;48(9):1553-61. Epub 2007 Aug 17.
Link
741. In Vivo Long-Term Imaging and Radioiodine Therapy by Sodium-Iodide Symporter Gene Expression Using a Lentiviral System Containing Ubiquitin C Promoter.
Kim HJ, Jeon YH, Kang JH, Lee YJ, Kim KI, Chung HK, Jeong JM, Lee DS, Lee MC, Chung JK.
Cancer Biol Ther. 2007 Apr 25;6(7)
Link
740. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI, Kang JH, Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC.
J Nucl Med. 2007 Sep;48(9):1553-61. Epub 2007 Aug 17
Link
739. In Vivo Long-Term Imaging and Radioiodine Therapy by Sodium-Iodide Symporter Gene Expression Using a Lentiviral System Containing Ubiquitin C Promoter.
Kim HJ, Jeon YH, Kang JH, Lee YJ, Kim KI, Chung HK, Jeong JM, Lee DS, Lee MC, Chung JK.
Cancer Biol Ther. 2007 Apr 25;6(7)
Link
738. Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine.
Jeon YH, Choi Y, Kim HJ, Kim CW, Jeong JM, Lee DS, Chung JK.
Int J Cancer. 2007 Oct 1;121(7):1593-9
Link